Status:
COMPLETED
Study of 0417 Ointment in the Treatment of Atopic Dermatitis
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affecte...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Atopic Dermatitis
- Good health with the exception of Atopic Dermatitis
- Percent Body Surface Area minimum requirements
Exclusion
- Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period.
- Subjects who have any systemic or dermatological disorders with the exception of Atopic Dermatitis
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
899 Patients enrolled
Trial Details
Trial ID
NCT01139450
Start Date
January 1 2008
End Date
August 1 2009
Last Update
October 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fougera Pharmaceuticals Inc.
Melville, New York, United States, 11747